Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs. Linder S, Severson TM, van der Mijn KJC, Nevedomskaya E, et al. Eur Urol 2023;84:455-460.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Linder S, Severson TM, van der Mijn KJC, Nevedomskaya E, et al. Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs. Eur Urol 2023;84:455-460.
PMID: 37271632